Literature DB >> 23721753

Caesarean section surgical techniques (CORONIS): a fractional, factorial, unmasked, randomised controlled trial.

E Abalos, V Addo, P Brocklehurst, M El Sheikh, B Farrell, S Gray, P Hardy, E Juszczak, J E Mathews, S Naz Masood, E Oyarzun, J Oyieke, J B Sharma, P Spark.   

Abstract

BACKGROUND: Variations exist in the surgical techniques used for caesarean section and many have not been rigorously assessed in randomised controlled trials. We aimed to assess whether any surgical techniques were associated with improved outcomes for women and babies.
METHODS: CORONIS was a pragmatic international 2×2×2×2×2 non-regular fractional, factorial, unmasked, randomised controlled trial that examined five elements of the caesarean section technique in intervention pairs. CORONIS was undertaken at 19 sites in Argentina, Chile, Ghana, India, Kenya, Pakistan, and Sudan. Each site was assigned to three of the five intervention pairs: blunt versus sharp abdominal entry; exteriorisation of the uterus for repair versus intra-abdominal repair; single-layer versus double-layer closure of the uterus; closure versus non-closure of the peritoneum (pelvic and parietal); and chromic catgut versus polyglactin-910 for uterine repair. Pregnant women were eligible if they were to undergo their first or second caesarean section through a planned transverse abdominal incision. Women were randomly assigned by a secure web-based number allocation system to one intervention from each of the three assigned pairs. All investigators, surgeons, and participants were unmasked to treatment allocation. The primary outcome was the composite of death, maternal infectious morbidity, further operative procedures, or blood transfusion (>1 unit) up to the 6-week follow-up visit. Women were analysed in the groups into which they were allocated. The CORONIS Trial is registered with Current Controlled Trials: ISRCTN31089967.
FINDINGS: Between May 20, 2007, and Dec 31, 2010, 15 935 women were recruited. There were no statistically significant differences within any of the intervention pairs for the primary outcome: blunt versus sharp entry risk ratio 1·03 (95% CI 0·91-1·17), exterior versus intra-abdominal repair 0·96 (0·84-1·08), single-layer versus double-layer closure 0·96 (0·85-1·08), closure versus non-closure 1·06 (0·94-1·20), and chromic catgut versus polyglactin-910 0·90 (0·78-1·04). 144 serious adverse events were reported, of which 26 were possibly related to the intervention. Most of the reported serious adverse events were known complications of surgery or complications of the reasons for the caesarean section.
INTERPRETATION: These findings suggest that any of these surgical techniques is acceptable. However, longer-term follow-up is needed to assess whether the absence of evidence of short-term effects will translate into an absence of long-term effects. FUNDING: UK Medical Research Council and WHO.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23721753     DOI: 10.1016/S0140-6736(13)60441-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  22 in total

Review 1.  A review of Caesarean section techniques and postoperative thromboprophylaxis at a tertiary hospital.

Authors:  Chang Qi Hester Lau; Tuck Chin Tiffany Wong; Eng Loy Tan; Devendra Kanagalingam
Journal:  Singapore Med J       Date:  2016-04-08       Impact factor: 1.858

2.  Home opioid use following cesarean delivery: How many opioid tablets should obstetricians prescribe?

Authors:  Payton Schmidt; Mitchell B Berger; Lori Day; Carolyn W Swenson
Journal:  J Obstet Gynaecol Res       Date:  2018-01-23       Impact factor: 1.730

3.  Uterine exteriorization versus in situ repair in Cesarean delivery: a systematic review and meta-analysis.

Authors:  Hon Sen Tan; Cameron R Taylor; Nadir Sharawi; Rehena Sultana; Karen D Barton; Ashraf S Habib
Journal:  Can J Anaesth       Date:  2021-11-22       Impact factor: 6.713

Review 4.  Closure versus non-closure of the peritoneum at caesarean section: short- and long-term outcomes.

Authors:  Anthony A Bamigboye; G Justus Hofmeyr
Journal:  Cochrane Database Syst Rev       Date:  2014-08-11

5.  Caesarean section surgical techniques: 3 year follow-up of the CORONIS fractional, factorial, unmasked, randomised controlled trial.

Authors:  E Abalos; V Addo; P Brocklehurst; M El Sheikh; B Farrell; S Gray; P Hardy; E Juszczak; J E Mathews; S Naz Masood; E Oyarzun; J Oyieke; J B Sharma; P Spark
Journal:  Lancet       Date:  2016-05-04       Impact factor: 79.321

6.  Cost-effectiveness of single-layer versus double-layer uterine closure during caesarean section on postmenstrual spotting: economic evaluation alongside a randomised controlled trial.

Authors:  Sanne I Stegwee; Ângela J Ben; Mohamed El Alili; Lucet F van der Voet; Christianne J M de Groot; Judith E Bosmans; Judith A F Huirne
Journal:  BMJ Open       Date:  2021-07-02       Impact factor: 2.692

Review 7.  Effect of Complementary Medicine on Pain Relief and Wound Healing after Cesarean Section: A Systematic Review.

Authors:  Azin Niazi; Maryam Moradi; Vahid Reza Askari; Neda Sharifi
Journal:  J Pharmacopuncture       Date:  2021-06-30

8.  Why do niches develop in Caesarean uterine scars? Hypotheses on the aetiology of niche development.

Authors:  A J M W Vervoort; L B Uittenbogaard; W J K Hehenkamp; H A M Brölmann; B W J Mol; J A F Huirne
Journal:  Hum Reprod       Date:  2015-09-25       Impact factor: 6.918

Review 9.  Selecting and measuring optimal outcomes for randomised controlled trials in surgery.

Authors:  Rhiannon C Macefield; Caroline E Boulind; Jane M Blazeby
Journal:  Langenbecks Arch Surg       Date:  2014-03       Impact factor: 3.445

10.  Suture Closure versus Non-Closure of Subcutaneous Fat and Cosmetic Outcome after Cesarean Section: A Randomized Controlled Trial.

Authors:  Heinrich Husslein; Martina Gutschi; Heinz Leipold; Christoph Herbst; Maximilian Franz; Christof Worda
Journal:  PLoS One       Date:  2014-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.